These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36198922)

  • 1. Secretomics Alterations and Astrocyte Dysfunction in Human iPSC of Leukoencephalopathy with Vanishing White Matter.
    Deng J; Zhang J; Gao K; Yan W; Zhou L; Jiang Y; Wang J; Wu Y
    Neurochem Res; 2022 Dec; 47(12):3747-3760. PubMed ID: 36198922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter.
    Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y
    CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.
    Zhou L; Li P; Chen N; Dai LF; Gao K; Liu YN; Shen L; Wang JM; Jiang YW; Wu Y
    CNS Neurosci Ther; 2019 Jun; 25(6):759-771. PubMed ID: 30720246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytes are central in the pathomechanisms of vanishing white matter.
    Dooves S; Bugiani M; Postma NL; Polder E; Land N; Horan ST; van Deijk AL; van de Kreeke A; Jacobs G; Vuong C; Klooster J; Kamermans M; Wortel J; Loos M; Wisse LE; Scheper GC; Abbink TE; Heine VM; van der Knaap MS
    J Clin Invest; 2016 Apr; 126(4):1512-24. PubMed ID: 26974157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoencephalopathy with vanishing white matter: a review.
    Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
    Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
    J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
    Miyamoto N; Maki T; Shindo A; Liang AC; Maeda M; Egawa N; Itoh K; Lo EK; Lok J; Ihara M; Arai K
    J Neurosci; 2015 Oct; 35(41):14002-8. PubMed ID: 26468200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanishing white matter: deregulated integrated stress response as therapy target.
    Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter.
    Leferink PS; Breeuwsma N; Bugiani M; van der Knaap MS; Heine VM
    Glia; 2018 Apr; 66(4):862-873. PubMed ID: 29285798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease.
    Cabilly Y; Barbi M; Geva M; Marom L; Chetrit D; Ehrlich M; Elroy-Stein O
    PLoS One; 2012; 7(10):e46715. PubMed ID: 23056417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanishing white matter.
    van der Knaap MS; Bugiani M; Abbink TEM
    Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter.
    Leferink PS; Dooves S; Hillen AEJ; Watanabe K; Jacobs G; Gasparotto L; Cornelissen-Steijger P; van der Knaap MS; Heine VM
    Ann Neurol; 2019 Nov; 86(5):780-792. PubMed ID: 31433864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
    Pan YX; Wu Y; Niu ZP; Jiang YW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
    Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
    Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response.
    Keefe MD; Soderholm HE; Shih HY; Stevenson TJ; Glaittli KA; Bowles DM; Scholl E; Colby S; Merchant S; Hsu EW; Bonkowsky JL
    Elife; 2020 Dec; 9():. PubMed ID: 33300869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction.
    Ng NS; Newbery M; Touffu A; Maksour S; Chung J; Carroll L; Zaw T; Wu Y; Ooi L
    CNS Neurosci Ther; 2023 Sep; 29(9):2481-2497. PubMed ID: 36971196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing white matter: a leukodystrophy due to astrocytic dysfunction.
    Bugiani M; Vuong C; Breur M; van der Knaap MS
    Brain Pathol; 2018 May; 28(3):408-421. PubMed ID: 29740943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy.
    Herrero M; Daw M; Atzmon A; Elroy-Stein O
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.
    Dietrich J; Lacagnina M; Gass D; Richfield E; Mayer-Pröschel M; Noble M; Torres C; Pröschel C
    Nat Med; 2005 Mar; 11(3):277-83. PubMed ID: 15723074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.